pubmed.ncbi.nlm.nih.gov

Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices - PubMed

Comparative Study

Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices

Sigrid E Sandner et al. J Heart Lung Transplant. 2008 May.

Abstract

Background: This study was designed to determine the effect of continuous vs pulsatile flow devices on renal function after left ventricular assist device (LVAD) implantation.

Methods: Ninety-two patients undergoing LVAD implantation as bridge-to-transplant therapy were retrospectively analyzed. Patients receiving continuous flow devices (n = 63, 68.5%) were compared with patients receiving pulsatile flow devices (n = 29, 31.5%). Renal function was assessed by 2 calculated glomerular filtration rates (GFR) using the Modification of Diet in Renal Disease (MDRD)-derived GFR (ml/min/1.73 m(2)) and the Cockcroft-Gault-derived creatinine clearance (CrCl, ml/min).

Results: Mean GFR/CrCl was comparable between the groups at LVAD implantation, in the post-implantation period, and at transplantation. Both groups had a significant increase in mean GFR at Week 1 post-implantation (continuous, 59.4 +/- 22.8 to 76.4 +/- 38.6, p = 0.001; pulsatile, 52.5 +/- 21.1 to 69.2 +/- 34.7; p = 0.007), Week 4 (continuous, 59.9 +/- 23.0 to 84.3 +/- 32.9; p < 0.001; pulsatile, 50.3 +/- 21.1 to 79.9 +/- 38.7, p = 0.007), and Week 12 (continuous, 60.3 +/- 23.1 to 75.3 +/- 30.2, p = 0.004; pulsatile, 55.5 +/- 23.1 to 74.2 +/- 27.2, p = 0.037) that was also seen with the Cockcroft-Gault-calculated CrCl. No significant increase occurred in mean GFR/CrCl to transplantation. Incidence of post-implantation renal failure was comparable between the groups (continuous, 38.1%; pulsatile, 31.0%; p = 0.512).

Conclusions: After LVAD implantation, patients with continuous flow devices and patients with pulsatile flow devices have comparable renal function.

PubMed Disclaimer

Cited by

Ventricular Assist Devices - Evolution of Surgical Heart Failure Treatment.
Wiedemann D, Haberl T, Riebandt J, Simon P, Laufer G, Zimpfer D. Wiedemann D, et al. Eur Cardiol. 2014 Jul;9(1):54-58. doi: 10.15420/ecr.2014.9.1.54. Eur Cardiol. 2014. PMID: 30310486 Free PMC article. Review.
Renal dysfunction and chronic mechanical circulatory support: from patient selection to long-term management and prognosis.
Brisco MA, Testani JM, Cook JL. Brisco MA, et al. Curr Opin Cardiol. 2016 May;31(3):277-86. doi: 10.1097/HCO.0000000000000278. Curr Opin Cardiol. 2016. PMID: 27022890 Free PMC article. Review.
Acute kidney injury and mortality following ventricular assist device implantation.
Naik A, Akhter SA, Fedson S, Jeevanandam V, Rich JD, Koyner JL. Naik A, et al. Am J Nephrol. 2014;39(3):195-203. doi: 10.1159/000358495. Epub 2014 Feb 15. Am J Nephrol. 2014. PMID: 24556808 Free PMC article.
Kidney dysfunction and left ventricular assist device support: a comprehensive perioperative review.
Coffin ST, Waguespack DR, Haglund NA, Maltais S, Dwyer JP, Keebler ME. Coffin ST, et al. Cardiorenal Med. 2015 Feb;5(1):48-60. doi: 10.1159/000369589. Epub 2015 Jan 9. Cardiorenal Med. 2015. PMID: 25759700 Free PMC article. Review.
Physiologic effects of continuous-flow left ventricular assist devices.
Healy AH, McKellar SH, Drakos SG, Koliopoulou A, Stehlik J, Selzman CH. Healy AH, et al. J Surg Res. 2016 May 15;202(2):363-71. doi: 10.1016/j.jss.2016.01.015. Epub 2016 Jan 20. J Surg Res. 2016. PMID: 27229111 Free PMC article. Review.

Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices - PubMed